Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling

Takashi Kohno, Toshihisa Anzai, Kotaro Naito, Yasuo Sugano, Yuichiro Maekawa, Toshiyuki Takahashi, Tsutomu Yoshikawa, Satoshi Ogawa

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Monocyte chemoattractant protein-1 (MCP-1) is a key mediator of left ventricular (LV) remodeling during the early phase of myocardial infarction (MI). The hypothesis tested was that myocardial MCP-1 expression would increase during the chronic phase of MI and an angiotensin-II type 1 receptor blocker (ARB) would attenuate macrophage infiltration through decreased myocardial MCP-1 expression. Methods and Results: MI was produced by ligation of the left coronary artery in Wistar rats, which were then randomized to treatment with vehicle (MI/C), candesartan (10mg·kg -1·day-1) for 6 weeks (MI/ARB0-6W), or candesartan for 2 weeks, starting 4 weeks after MI (MI/ARB4-6W). LV systolic and end-diastolic pressures 6 weeks after MI were decreased in MI/ARB0-6W compared with MI/C or MI/ARB4-6W, however, there were no differences in other hemodynamic or echocardiographic parameters among infarcted rat groups. Both long-and short-term treatments with ARB similarly reduced mRNA expressions of MCP-1, transforming growth factor-β1, and procollagen type I and III, macrophage infiltration, and myocardial fibrosis in the border zone. Conclusions: In post-MI heart failure, ARB attenuated MCP-1 expression and macrophage infiltration in the border zone, resulting in less myocardial fibrosis. ARB may exert its beneficial effect, at least in part, by inhibiting myocardial macrophage-related inflammation.

Original languageEnglish
Pages (from-to)1685-1692
Number of pages8
JournalCirculation Journal
Volume72
Issue number10
DOIs
Publication statusPublished - 2008

Fingerprint

Ventricular Remodeling
Angiotensin Receptors
Chemokine CCL2
Infarction
Macrophages
Myocardial Infarction
Angiotensin II Type 1 Receptor Blockers
Fibrosis
Transforming Growth Factors
Collagen Type I
Ligation
Wistar Rats
Coronary Vessels
Heart Failure
Hemodynamics

Keywords

  • Chemokines
  • Fibrosis
  • Heart failure
  • Inflammation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. / Kohno, Takashi; Anzai, Toshihisa; Naito, Kotaro; Sugano, Yasuo; Maekawa, Yuichiro; Takahashi, Toshiyuki; Yoshikawa, Tsutomu; Ogawa, Satoshi.

In: Circulation Journal, Vol. 72, No. 10, 2008, p. 1685-1692.

Research output: Contribution to journalArticle

Kohno, Takashi ; Anzai, Toshihisa ; Naito, Kotaro ; Sugano, Yasuo ; Maekawa, Yuichiro ; Takahashi, Toshiyuki ; Yoshikawa, Tsutomu ; Ogawa, Satoshi. / Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. In: Circulation Journal. 2008 ; Vol. 72, No. 10. pp. 1685-1692.
@article{c2056fddaf2443e58134ef7876e1c7f3,
title = "Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling",
abstract = "Background: Monocyte chemoattractant protein-1 (MCP-1) is a key mediator of left ventricular (LV) remodeling during the early phase of myocardial infarction (MI). The hypothesis tested was that myocardial MCP-1 expression would increase during the chronic phase of MI and an angiotensin-II type 1 receptor blocker (ARB) would attenuate macrophage infiltration through decreased myocardial MCP-1 expression. Methods and Results: MI was produced by ligation of the left coronary artery in Wistar rats, which were then randomized to treatment with vehicle (MI/C), candesartan (10mg·kg -1·day-1) for 6 weeks (MI/ARB0-6W), or candesartan for 2 weeks, starting 4 weeks after MI (MI/ARB4-6W). LV systolic and end-diastolic pressures 6 weeks after MI were decreased in MI/ARB0-6W compared with MI/C or MI/ARB4-6W, however, there were no differences in other hemodynamic or echocardiographic parameters among infarcted rat groups. Both long-and short-term treatments with ARB similarly reduced mRNA expressions of MCP-1, transforming growth factor-β1, and procollagen type I and III, macrophage infiltration, and myocardial fibrosis in the border zone. Conclusions: In post-MI heart failure, ARB attenuated MCP-1 expression and macrophage infiltration in the border zone, resulting in less myocardial fibrosis. ARB may exert its beneficial effect, at least in part, by inhibiting myocardial macrophage-related inflammation.",
keywords = "Chemokines, Fibrosis, Heart failure, Inflammation",
author = "Takashi Kohno and Toshihisa Anzai and Kotaro Naito and Yasuo Sugano and Yuichiro Maekawa and Toshiyuki Takahashi and Tsutomu Yoshikawa and Satoshi Ogawa",
year = "2008",
doi = "10.1253/circj.CJ-08-0115",
language = "English",
volume = "72",
pages = "1685--1692",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "10",

}

TY - JOUR

T1 - Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling

AU - Kohno, Takashi

AU - Anzai, Toshihisa

AU - Naito, Kotaro

AU - Sugano, Yasuo

AU - Maekawa, Yuichiro

AU - Takahashi, Toshiyuki

AU - Yoshikawa, Tsutomu

AU - Ogawa, Satoshi

PY - 2008

Y1 - 2008

N2 - Background: Monocyte chemoattractant protein-1 (MCP-1) is a key mediator of left ventricular (LV) remodeling during the early phase of myocardial infarction (MI). The hypothesis tested was that myocardial MCP-1 expression would increase during the chronic phase of MI and an angiotensin-II type 1 receptor blocker (ARB) would attenuate macrophage infiltration through decreased myocardial MCP-1 expression. Methods and Results: MI was produced by ligation of the left coronary artery in Wistar rats, which were then randomized to treatment with vehicle (MI/C), candesartan (10mg·kg -1·day-1) for 6 weeks (MI/ARB0-6W), or candesartan for 2 weeks, starting 4 weeks after MI (MI/ARB4-6W). LV systolic and end-diastolic pressures 6 weeks after MI were decreased in MI/ARB0-6W compared with MI/C or MI/ARB4-6W, however, there were no differences in other hemodynamic or echocardiographic parameters among infarcted rat groups. Both long-and short-term treatments with ARB similarly reduced mRNA expressions of MCP-1, transforming growth factor-β1, and procollagen type I and III, macrophage infiltration, and myocardial fibrosis in the border zone. Conclusions: In post-MI heart failure, ARB attenuated MCP-1 expression and macrophage infiltration in the border zone, resulting in less myocardial fibrosis. ARB may exert its beneficial effect, at least in part, by inhibiting myocardial macrophage-related inflammation.

AB - Background: Monocyte chemoattractant protein-1 (MCP-1) is a key mediator of left ventricular (LV) remodeling during the early phase of myocardial infarction (MI). The hypothesis tested was that myocardial MCP-1 expression would increase during the chronic phase of MI and an angiotensin-II type 1 receptor blocker (ARB) would attenuate macrophage infiltration through decreased myocardial MCP-1 expression. Methods and Results: MI was produced by ligation of the left coronary artery in Wistar rats, which were then randomized to treatment with vehicle (MI/C), candesartan (10mg·kg -1·day-1) for 6 weeks (MI/ARB0-6W), or candesartan for 2 weeks, starting 4 weeks after MI (MI/ARB4-6W). LV systolic and end-diastolic pressures 6 weeks after MI were decreased in MI/ARB0-6W compared with MI/C or MI/ARB4-6W, however, there were no differences in other hemodynamic or echocardiographic parameters among infarcted rat groups. Both long-and short-term treatments with ARB similarly reduced mRNA expressions of MCP-1, transforming growth factor-β1, and procollagen type I and III, macrophage infiltration, and myocardial fibrosis in the border zone. Conclusions: In post-MI heart failure, ARB attenuated MCP-1 expression and macrophage infiltration in the border zone, resulting in less myocardial fibrosis. ARB may exert its beneficial effect, at least in part, by inhibiting myocardial macrophage-related inflammation.

KW - Chemokines

KW - Fibrosis

KW - Heart failure

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=52949098784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949098784&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-08-0115

DO - 10.1253/circj.CJ-08-0115

M3 - Article

VL - 72

SP - 1685

EP - 1692

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 10

ER -